About Indivior (OTCMKTS:INVVY)
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence worldwide. The companys product candidates focus on treating opioid use disorder, alcohol use disorder, overdose rescue, and CNS disorders/schizophrenia. It markets and promotes SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex. The company was incorporated in 2014 and is headquartered in Richmond, Virginia.
Industry, Sector and Symbol
Trailing P/E Ratio68.15
Forward P/E Ratio16.23
Sales & Book Value
Annual Sales$1.09 billion
Price / Sales3.60
Cash Flow$1.86 per share
Price / Cash14.66
Book Value($2.05) per share
Price / Book-13.30
Net Income$58 million
Return on Equity-89.83%
Return on Assets21.92%
Indivior (OTCMKTS:INVVY) Frequently Asked Questions
What is Indivior's stock symbol?
Indivior trades on the OTCMKTS under the ticker symbol "INVVY."
How were Indivior's earnings last quarter?
Indivior Plc (OTCMKTS:INVVY) released its quarterly earnings data on Thursday, February, 15th. The company reported $0.35 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.50 by $0.15. The business had revenue of $265 million for the quarter. Indivior had a net margin of 5.31% and a negative return on equity of 89.83%. View Indivior's Earnings History.
When will Indivior make its next earnings announcement?
Who are some of Indivior's key competitors?
Some companies that are related to Indivior include Bio-Rad Laboratories (BIO), Beigene (BGNE), West Pharmaceutical Services (WST), Stada Arzneimittel (STDAF), Grifols SA, Barcelona (GRFS), Olympus (OCPNY), Hill-Rom (HRC), BIO-TECHNE (TECH), Charles River Laboratories Intl. (CRL), Patheon (PTHN), Gn Store Nord (GNNDY), Envision Healthcare (EVHC), Hutchison China MediTech (HCM), Insulet (PODD), Swedish Orphan Bio (SWTUY), Orion (ORINY), LivaNova (LIVN) and Sartorius (SARTF).
How do I buy Indivior stock?
Shares of Indivior can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Indivior's stock price today?
One share of Indivior stock can currently be purchased for approximately $27.26.
How big of a company is Indivior?
Indivior has a market capitalization of $3.93 billion and generates $1.09 billion in revenue each year. The company earns $58 million in net income (profit) each year or $0.40 on an earnings per share basis.
How can I contact Indivior?
Indivior's mailing address is 103-105 Bath Road, Slough X0, SL1 3UH. The company can be reached via phone at 44-17-5321-7800 or via email at [email protected]
MarketBeat Community Rating for Indivior (INVVY)MarketBeat's community ratings are surveys of what our community members think about Indivior and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Indivior (OTCMKTS:INVVY) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Indivior (OTCMKTS:INVVY) Earnings History and Estimates Chart
Indivior (OTCMKTS INVVY) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/2/2018|| || || || || || || || |
|2/15/2018||Q4 2017||$0.50||$0.35||$265.00 million||View||N/A|
|11/2/2017||Q3 2017||$0.30||$275.00 million||View||N/A|
|7/27/2017||Q2 2017||$0.60||$288.00 million||View||N/A|
|5/3/2017||Q1 2017||$0.55||$265.00 million||View||N/A|
|11/2/2016||Q3 2016||$0.50||$268.00 million||View||N/A|
|7/29/2016||Q2 2016||$0.55||$274.00 million||View||N/A|
|5/3/2016||Q1 2016||$0.40||$258.00 million||View||N/A|
|4/10/2015||Q4 2014||$0.65||$272.00 million||View||N/A|
Indivior (OTCMKTS:INVVY) Earnings Estimates
Current Year EPS Consensus Estimate: $1.68 EPS
Next Year EPS Consensus Estimate: $1.45 EPS
Dividend History for Indivior (OTCMKTS:INVVY)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Indivior (OTCMKTS INVVY)
No insider trades for this company have been tracked by MarketBeat.com
Indivior (OTCMKTS INVVY) News Headlines
Indivior (OTCMKTS:INVVY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Indivior (OTCMKTS INVVY) Stock Chart for Monday, February, 19, 2018